Mumbai, June 2 -- Rifaximin tablets are indicated for the treatment of irritable bowel syndrome with diarrhoea ... Shares of Zydus Lifesciences shed 0.53% to Rs 924.95 on the BSE.

Zydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The drug, a generic version of Sprycel ...

Zydus Pharmaceuticals announced a voluntary recall of one lot of Warfarin 2mg Tablets because they have been found to be oversized in a product complaint. The affected product has Lot #MM5767 and ...

The shares of Zydus Lifesciences Limited on Friday at 3:30 pm IST closed at Rs 646.50, up by 0.42 per cent. Read Also Zydus Receives Final Approval From The USFDA For Darunavir Tablets ...

Zydus recently received the Food and Drug Administration’s green light for fludrocortisone acetate tablets, 0.1 mg. Fludrocortisone acetate tablets are indicated as partial replacement therapy ...

Dexamethasone tablets, 1 mg had a market value of $1.8 million, per IQVIA March 2024 data. Zydus also received the green light from the FDA for generic Dapsone Gel, 7.5%, Zydus Lifesciences said ...

Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market and is prepared to launch Mirabegron Extended-Release Tablets ...

Zydus Lifesciences US subsidiary Zydus Pharmaceuticals USA Inc has received final approval from the United States Food and Drug Administration USFDA to market Brivaracetam Tablets USP 10 mg 25 mg ...

Methenamine Hippurate tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad. Methenamine Hippurate tablets had annual sales of USD 32.6 mn in the United States (IQVIA MAT January 2025).

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. Sun, May 04, 2025 | Updated 14: ...

Zydus Receives Final Approval From The USFDA For Erythromycin Tablets Erythromycin Tablets USP, 250 mg and 500mg had annual sales of USD 23mn in the United States. FPJ Web Desk Updated: Friday ...

Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Brivaracetam Tablets USP 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg.